Medicenna Therapeutics Corp.
(Toronto Stock Exchange : MDNA)

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 3.30%151.850.0%$2783.13m
BNGOBioNano Genomics, Inc. -2.94%12.210.0%$2518.37m
GILDGilead Sciences, Inc. -2.14%66.701.0%$655.34m
AMGNAmgen, Inc. 0.58%258.601.3%$584.65m
REGNRegeneron Pharmaceuticals, Inc. -0.75%544.102.7%$497.98m
ALXNAlexion Pharmaceuticals, Inc. 0.27%161.752.0%$475.34m
CRSPCRISPR Therapeutics AG -6.46%169.530.6%$445.57m
ILMNIllumina, Inc. -0.11%420.553.5%$443.81m
NVAXNovavax, Inc. -3.27%127.1692.9%$407.11m
VRTXVertex Pharmaceuticals, Inc. -1.52%237.641.9%$379.54m
SRPTSarepta Therapeutics, Inc. -3.60%92.6513.8%$343.41m
BIIBBiogen, Inc. -1.41%271.671.7%$323.61m
BNTXBioNTech SE -3.91%106.290.0%$307.94m
EXASEXACT Sciences Corp. -8.37%141.0419.6%$251.66m
PACBPacific Biosciences of California, Inc. -8.54%32.887.4%$199.92m

Company Profile

Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company which engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers. The company was founded by Fahar Merchant and Rosemina Merchant on February 2, 2015 and is headquartered in Toronto, Canada.